文献速递肝病

B细胞通过IL-15Rα-IL-15信号驱动CCR5+CD4+组织驻留记忆T细胞细胞毒性参与原发性胆汁性胆管炎

B cells drive CCR5+CD4+ tissue-resident memory T-cell cytotoxicity via IL-15Rα-IL-15 signaling in primary biliary cholangitis.
PubMed 文献 · J Hepatol · 2025-07-17

该研究通过肝组织免疫组化、流式细胞术、RNA测序及类器官共培养等方法,发现原发性胆汁性胆管炎(PBC)患者肝内IL-15Rα+细胞显著增多且主要富集于浆母细胞B细胞群,与肝炎症严重程度正相关;IL-15Rα+ B细胞分泌CCL3招募CCR5+CD4+组织驻留记忆T(TRM)细胞,并通过IL-15Rα/IL-15信号增强其效应功能,CCR5+CD4+ TRM细胞通过颗粒酶A介导的gasdermin B裂解驱动胆管细胞焦亡;阻断IL-15Rα/IL-15信号可改善PBC小鼠模型肝损伤。

要点

  • PBC患者肝内IL-15Rα+细胞显著增多,主要富集于浆母细胞B细胞群,与肝炎症严重程度正相关。
  • IL-15Rα+ B细胞分泌CCL3招募CCR5+CD4+ TRM细胞,经IL-15Rα/IL-15信号增强其效应功能。
  • CCR5+CD4+ TRM细胞通过颗粒酶A介导的gasdermin B裂解驱动胆管细胞焦亡。

核心结论

  • PBC中存在IL-15Rα+ B细胞通过激活CCR5+CD4+ TRM细胞参与胆管损伤的致病机制,该机制可能与其它免疫效应通路协同驱动疾病进展。

研究设计与样本

  • 对健康对照(n=10)及PBC(n=94)、自身免疫性肝炎(n=32)、慢性乙型肝炎(n=10)、代谢功能障碍相关脂肪性肝炎(n=7)患者肝组织行免疫组化染色评估IL-15Rα表达。
  • 采用流式细胞术分析肝内IL-15Rα+ B细胞与CD4+ TRM细胞,RNA测序描绘体外诱导B细胞及肝内白细胞的转录组特征。
  • 采用胆管细胞类器官共培养系统评估TRM细胞细胞毒性,并以抗IL-15/IL-15Rα单克隆抗体处理dnTGFβRII小鼠进行体内验证。

主要发现

  • IL-15Rα+细胞在PBC患者肝脏中显著增多,主要集中于浆母细胞B细胞群,并与肝炎症严重程度正相关。
  • PBC肝内IL-15Rα+ B细胞富集于胆管周围,分泌CCL3招募CCR5+CD4+ TRM细胞,并通过IL-15Rα/IL-15信号增强其效应功能。
  • CCR5+CD4+ TRM细胞通过颗粒酶A介导的gasdermin B裂解驱动胆管细胞焦亡。
  • 阻断IL-15Rα/IL-15信号可改善PBC小鼠模型的肝损伤。

局限性

  • IL-15Rα/IL-15信号对其他慢性肝病的调控作用仍有待进一步阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: IL-15Rα mediates immune responses by binding and trans-presenting IL-15 to tissue-resident memory T (TRM) cells, enabling sustained activation. Given the pivotal role of IL-15Rα/IL-15 signaling in autoimmune diseases, elucidating its organ-specific expression and pathogenic functions in primary biliary cholangitis (PBC) remains crucial. METHODS: Immunohistochemical staining was performed on liver tissues from healthy controls (n = 10) and patients with PBC (n = 94), autoimmune hepatitis (n = 32), chronic hepatitis B (n = 10), and metabolic dysfunction-associated steatohepatitis (n = 7) to assess IL-15Rα expression. Flow cytometric analysis was used to characterize intrahepatic IL-15Rα+ B cells and CD4+ TRM cells. RNA sequencing was employed to delineate the transcriptomic signatures of in vitro-induced B cells and intrahepatic leukocytes. A cholangiocyte organoid co-culture system was employed to assess TRM cell cytotoxicity. Moreover, dnTGFβRII mice treated with an anti-IL-15/IL-15Rα monoclonal antibody were used for in vivo validation. RESULTS: IL-15Rα+ cells were significantly increased in the livers of patients with PBC, were primarily concentrated within the plasmablast B-cell population, and positively correlated with the severity of hepatic inflammation. IL-15Rα+ B cells, enriched around bile ducts in PBC livers, secrete CCL3 to recruit CCR5+CD4+ TRM cells, enhancing their effector functions via IL-15Rα/IL-15 signaling. Notably, CCR5+CD4+ TRM cells drive cholangiocyte pyroptosis through granzyme A-mediated gasdermin B cleavage. Furthermore, blockade of IL-15Rα/IL-15 signaling ameliorates liver injury in PBC mouse models. CONCLUSIONS: Our findings reveal an important pathogenic mechanism in PBC wherein IL-15Rα+ B cells contribute to biliary injury by activating CCR5+CD4+ TRM cells. This mechanism likely works in concert with other immune effector pathways in driving disease progression. IMPACT AND IMPLICATIONS: This study reveals that IL-15Rα-expressing B cells manifest a pro-inflammatory phenotype and promote biliary injury by impairing immune homeostasis through aberrant activation of tissue-resident memory T cells during primary biliary cholangitis progression. Although we now offer a new paradigm explaining how IL-15 trans-presentation is regulated in a B cell-dependent manner in primary biliary cholangitis, the regulatory effects of IL-15Rα/IL-15 signaling on other chronic liver diseases remain to be further elucidated.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Pu X, Liu Y, Lyu Z, et al. B cells drive CCR5+CD4+ tissue-resident memory T-cell cytotoxicity via IL-15Rα-IL-15 signaling in primary biliary cholangitis. J Hepatol. 2025. PMID: 40683604. doi:10.1016/j.jhep.2025.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。